Literature DB >> 15778380

Smad3 deficiency in mast cells provides efficient host protection against acute septic peritonitis.

Yutaka Kanamaru1, Koji Sumiyoshi, Hiroko Ushio, Hideoki Ogawa, Ko Okumura, Atsuhito Nakao.   

Abstract

Mast cells play an important role in innate immunity as well as in allergic reaction. However, regulatory mechanisms underlying mast cell-mediated innate immune responses remain largely unknown. Here we determined whether Smad3, a major signal transducer of TGF-beta, regulates innate immune response by mast cells against Gram-negative bacteria. Bone marrow-derived mast cells (BMMC) obtained from Smad3 null mutant mice showed augmented capacity to produce proinflammatory cytokines upon stimulation with a Gram-negative bacteria-associated product, LPS. In acute septic peritonitis model induced by cecal ligation and puncture, mast cell-deficient W/W(v) mice reconstituted with Smad3 null BMMC had significantly higher survival rate than W/W(v) mice reconstituted with wild-type BMMC, which was associated with higher production of proinflammatory cytokines in the peritoneal cavity. These in vitro and in vivo results suggest that Smad3 in mast cells functions as inhibitory for mast cell-mediated innate immune response against Gram-negative bacteria. Suppression of Smad3 expression in mast cells may thus have therapeutic potential for Gram-negative bacterial infection such as acute septic peritonitis by augmenting innate immune responses of mast cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778380     DOI: 10.4049/jimmunol.174.7.4193

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Approaches for analyzing the roles of mast cells and their proteases in vivo.

Authors:  Stephen J Galli; Mindy Tsai; Thomas Marichal; Elena Tchougounova; Laurent L Reber; Gunnar Pejler
Journal:  Adv Immunol       Date:  2015-02-07       Impact factor: 3.543

2.  Mast cells are an essential component of human radiation proctitis and contribute to experimental colorectal damage in mice.

Authors:  Karl Blirando; Fabien Milliat; Isabelle Martelly; Jean-Christophe Sabourin; Marc Benderitter; Agnès François
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 3.  Potential effector and immunoregulatory functions of mast cells in mucosal immunity.

Authors:  L L Reber; R Sibilano; K Mukai; S J Galli
Journal:  Mucosal Immunol       Date:  2015-02-11       Impact factor: 7.313

4.  Novel regulators of the systemic response to lipopolysaccharide.

Authors:  Ivana V Yang; Scott Alper; Brad Lackford; Holly Rutledge; Laura A Warg; Lauranell H Burch; David A Schwartz
Journal:  Am J Respir Cell Mol Biol       Date:  2010-12-03       Impact factor: 6.914

5.  Mast cell cathelicidin antimicrobial peptide prevents invasive group A Streptococcus infection of the skin.

Authors:  Anna Di Nardo; Kenshi Yamasaki; Robert A Dorschner; Yuping Lai; Richard L Gallo
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

6.  The transcription factor Zeb2 regulates signaling in mast cells.

Authors:  Emilia Alina Barbu; Juan Zhang; Elsa H Berenstein; Jacqueline R Groves; Lauren M Parks; Reuben P Siraganian
Journal:  J Immunol       Date:  2012-05-04       Impact factor: 5.422

7.  Smad3 signaling in the regenerating liver: implications for the regulation of IL-6 expression.

Authors:  Michael Kremer; Gakuhei Son; Kun Zhang; Sherri M Moore; Amber Norris; Giulia Manzini; Michael D Wheeler; Ian N Hines
Journal:  Transpl Int       Date:  2014-05-22       Impact factor: 3.782

8.  TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.

Authors:  Takashi Ando; Jiro Ichikawa; Masanori Wako; Kyosuke Hatsushika; Yoshiyuki Watanabe; Michitomo Sakuma; Kachio Tasaka; Hideoki Ogawa; Yoshiki Hamada; Hideo Yagita; Atsuhito Nakao
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

9.  A novel prognosis marker based on combined preoperative carcinoembryonic antigen and systemic inflammatory response for resectable gastric cancer.

Authors:  Yubin Ma; Junpeng Lin; Jianxian Lin; Junfang Hou; Qin Xiao; Fang Yu; Zhijun Ma; Ping Li; Ruhong Tu; Jianwei Xie; Chaohui Zheng; Su Yan; Changming Huang
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

10.  Identification of SMAD3 as a Novel Mediator of Inflammation in Human Myometrium In Vitro.

Authors:  Martha Lappas
Journal:  Mediators Inflamm       Date:  2018-09-27       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.